This is a synthetic peptide designed for use in combination with anti-FANCA antibody (Catalog #: ARP41678_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FANCA
Reactivité: Humain, Souris, Rat
Hôte: Synthetic
BP
Indications d'application
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
FANCA
(Fanconi Anemia Group A Protein (FANCA))
Synonymes
FA Peptide, FA-H Peptide, FA1 Peptide, FAA Peptide, FACA Peptide, FAH Peptide, FANCH Peptide, AW208693 Peptide, Fanconi anemia complementation group A Peptide, Fanconi anemia, complementation group A Peptide, FANCA Peptide, Fanca Peptide
Sujet
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FAN
Alias Symbols: FA, FA-H, FA1, FAA, FACA, FAH, FANCH, MGC75158
Protein Interaction Partner: BRCA1,FANCA,FANCG,AKT1,BRCA1,CDK1,FANCA,FANCC,FANCE,FANCF,FANCG,HES1,IKBKB,SMARCA4,SMARCC1,SMARCD3,SNX5,SPTAN1,AKT1,ALDOA,ATP5B,AZIN1,BAT1,BLM,BRCA1,C17orf70,C19orf40,CCT3,CD79A,CDK1,CHUK,DAXX,DNAJB1,DUS4L,ENO1,ERCC4,FANCA,FANCB,FANCC,FANCE,FANCF,FANCG,FANCL,FANCM,GNB2,HPRT1,HSP90AA1,HSP90B1,IFIT3,IKBKB,KRT1,LIPG,MKNK1,MX1,NAMPT,NUB1,PRPF31,PSMA5,RMI1,RPA1,RPL18,SGK1,SMARCA4,SNX5,SPTA1,SPTAN1,TAF10,TCERG1,TCP1,TOP3A,TPT1,YDL160C-A,YOL086W-A,ZNF24